Not Yet RecruitingNot Applicable

Relapse Management Group Psychoeducation Program

60 participantsStarted 2026-02-01

Plain-language summary

This study was planned to be conducted between February and March 2026, with a total of 60 patients diagnosed with schizophrenia who met the inclusion criteria and were followed at the community mental health center in the Psychiatry Building of Ankara Etlik City Hospital. 30 patients were in the experimental group and 30 were in the control group.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Age 18 and over * Able to speak and understand Turkish * Written consent obtained * Being a patient diagnosed with schizophrenia who is being monitored at the relevant institution during the study period * Being in remission Exclusion Criteria * Those who have previously received or are currently receiving psychoeducation on relapse management * Those who do not attend community mental health center follow-ups regularly * Those with mental retardation that may prevent participation in psychoeducation * Those in the relapse phase of the disease

What they're measuring

Early Warning Signs of Relapse Questionnaire

Timeframe: Change from before implementation, after the practice is completed, 4 weeks after the practice is finished.

Functional Recovery Scale for Patients with Schizophrenia

Timeframe: Change from before implementation, after the practice is completed, 4 weeks after the practice is finished.

Trial details

NCT IDNCT07327944

SponsorAnkara Etlik City Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-02-28

Contact for this trial

Bahar Akkaya

0312 797 0000 akkayabahar2130@icloud.com

View on ClinicalTrials.gov More Relapse Management trials